Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Contrast media injectors are devices used to inject contrast media agents into the bloodstream of patients, to enable visualization of various pathologies through X-ray, computed tomography, magnetic resonance, or other medical imaging devices. GlobalData uses proprietary data and analytics to provide a comprehensive report on the contrast media injectors devices market, including market shares of different players within Belgium. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Belgium Contrast Media Injectors Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2021, GlobalData’s Market Model methodology determined that the leading player in the contrast media injectors market in Belgium was Imaxeon followed by Guerbet, Bracco Imaging and Ulrich.

Computed tomography (CT) injectors, magnetic resonance imaging (MRI) injectors and angiographic injectors have been included in this category. CT injectors are devices used in conjunction with CT systems to inject contrast media agents into the blood stream of patients. MRI injectors are devices used in conjunction with MRI systems to inject contrast media agents into the blood stream of patients. Angiographic Injectors are devices used during cardiac and vascular angiographic procedures to inject contrast media agents into the blood stream of patients.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the contrast media injectors devices market within Belgium was expected to be over $0.4m in 2021.

For the latest complete market share analysis of contrast media injectors device market in Belgium, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.